Call us or schedule a teleconsultation to further inquire about treatment option
Wegovy Pill (Oral Semaglutide 25 mg Daily) According to the FDA approval announcement dated December 22, 2025, the Wegovy pill is indicated for the same population as the injection formulation
Patients start with lower doses and gradually increase to the target therapeutic level
Last reviewed: June 4, 2026 Last updated: June 4, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Some people who took retatrutide reported feeling nauseous or dealt with diarrhea, constipation or vomiting
Many people also experience difficulty with certain foods, particularly those high in fat or fiber